595 POSTER First Phase I trial of NKTR-102 (PEG-irinotecan)...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

595 POSTER First Phase I trial of NKTR-102 (PEG-irinotecan) reveals early evidence of broad anti-tumor activity in three schedules

D.D. Von Hoff, G. Jameson, M.J. Borad, L.S. Rosen, J. Utz, S. Dhar, L. Acosta, T. Barker, J. Walling, J.T. Hamm
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72529-1
File:
PDF, 63 KB
english, 2008
Conversion to is in progress
Conversion to is failed